CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy of GEN3009 (DuoHexaBody®-CD37) in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - A First-in-Human, Open-label, Phase 1/2a Dose Escalation Trial With Dose Expansion Cohorts

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04358458
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:10.584278+00:00
Published At: 2024-08-13T00:00:00+00:00
Record Updated At: 2024-10-24
Results Posted At: 2024-08-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diffuse Large B-cell Lymphoma", "Follicular Lymphoma", "Marginal Zone Lymphoma", "Small Lymphocytic Lymphoma", "Mantle Cell Lymphoma", "Chronic Lymphocytic Leukemia", "High-grade B-cell Lymphoma", "Primary Mediastinal Large B-cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-10-24"
protocolSection.identificationModule.nctId: "NCT04358458"
protocolSection.identificationModule.officialTitle: "Safety and Efficacy of GEN3009 (DuoHexaBody\u00ae-CD37) in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - A First-in-Human, Open-label, Phase 1/2a Dose Escalation Trial With Dose Expansion Cohorts"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-08-13"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.